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Hepatitis E (HEV) has traditionally been thought to be a
disease of developing countries. In this setting, HEV
causes hepatitis in young adults. It is generally a self-
limiting illness, with a good prognosis, except in preg-
nant women and patients with pre-existing chronic liver
disease, in whom the mortality is 20% and 70%
respectively.
Traditionally HEV was considered rare in developed
countries, and confined to travellers returning from
endemic areas. However, recent data has shown that
locally acquired HEV infection is common in developed
countries. Acute HEV infection in this setting is caused
by HEV genotype 3 and appears to have a predilection
for middle aged/elderly males. It has a significant mor-
bidity (15%) and carries an adverse prognosis in chronic
liver disease. HEV infection is commonly misdiagnosed
as drug-induced liver injury. The source and route of
infection are currently uncertain, but evidence suggests
that HEV genotype 3 is a porcine zoonosis, which can
be transmitted via the human food chain.
Until very recently chronic HEV infection was thought
not to occur. However studies from Europe have shown
that HEV genotype 3 can cause chronic infection with
rapidly progressive cirrhosis in patients with immuno-
compromise. This includes patients taking immunosup-
pressive therapy following solid organ transplantation
and patients with HIV-1 infection (NEJM 2009; 361(10):
1025-7).
HEV IgG seroprevalence in developed countries is
variable, with rates of 16% reported from the UK and
SW France. These data indicate that HEV infection is
either commonly subclinical, or commonly overlooked
as a diagnostic possibility. However, the burden of HEV
disease in both the developing and developed world is
currently uncertain. The worldwide burden of chronic
HEV infection may prove to be more considerable than
previously thought likely, as countries where HEV is
endemic also have a high seroprevalence of HIV.
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